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Summary
Aging is a multifactorial process where deterioration of
body functions is driven by stochastic damage while
counteracted by distinct genetically encoded repair
systems. To better understand the genetic component of
aging, many studies have addressed the gene and protein
expression proﬁles of various aging model systems
engaging different organisms from yeast to human. The
recently identiﬁed small non-coding miRNAs are potent
post-transcriptional regulators that can modify the
expression of up to several hundred target genes per sin-
gle miRNA, similar to transcription factors. Increasing evi-
dence shows that miRNAs contribute to the regulation of
most if not all important physiological processes, includ-
ing aging. However, so far the contribution of miRNAs to
age-related and senescence-related changes in gene
expression remains elusive. To address this question, we
have selected four replicative cell aging models including
endothelial cells, replicated CD8
+ T cells, renal proximal
tubular epithelial cells, and skin ﬁbroblasts. Further
included were three organismal aging models including
foreskin, mesenchymal stem cells, and CD8
+ T cell popula-
tions from old and young donors. Using locked nucleic
acid-based miRNA microarrays, we identiﬁed four com-
monly regulated miRNAs, miR-17 down-regulated in all
seven; miR-19b and miR-20a, down-regulated in six mod-
els; and miR-106a down-regulated in ﬁve models.
Decrease in these miRNAs correlated with increased tran-
script levels of some established target genes, especially
the cdk inhibitor p21⁄CDKN1A. These results establish
miRNAs as novel markers of cell aging in humans.
Key words: aging; miR-106a; miR-17; miR-17-92 cluster;
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Continuous stochastic damage contributes to the gradual atten-
uation of physiologic functions, which are partially alleviated by
genetically encoded repair systems (Kirkwood, 2008). Genetic
determinants, which have a direct impact on these biological
processes can be characterized by either studying model organ-
isms that are amenable to genetic manipulations (Lepperdinger
et al., 2008), or by applying functional genomic methods. Both
strategies have helped to identify genes and proteins, which
potentially modulate the aging process. Proteins identiﬁed in
various studies have been compiled in a database only recently
(de Magalhaes et al., 2009). Yet hardly any study has so far
addressed the role of miRNAs during aging (Bates et al., 2009;
Grillari & Grillari-Voglauer, 2010).
MiRNAs are a class of small non-coding silencing RNAs of
approximately 22 nucleotides in length (Ghildiyal & Zamore,
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Aging Cell (2010) 9, pp291–296 Doi:10.1111/j.1474-9726.2010.00549.x2009). They confer speciﬁcity to the RNA-induced silencing
complex that either degrades or translationally represses target
mRNAs (Bhattacharyya et al., 2006; Carthew & Sontheimer,
2009). As the recognition of target mRNAs mainly depends on
the small seed region within the mature miRNA, a single miRNA
potentially regulates up to several hundred mRNA targets, thus
orchestrating a large variety of cellular processes (Lim et al.,
2005; Stefani & Slack, 2008).
Here, we have set out to systematically compare miRNA
transcription proﬁles in old vs. young human cells. Employed
were in vitro replicative senescence of endothelial cells (Chang
et al., 2005; Hampel et al., 2006), renal proximal tubular epi-
thelial cells (Wieser et al., 2008), skin ﬁbroblasts (Hutter et al.,
2002; Stockl et al., 2006) as well as an intra-individual com-
parison of in vivo replicatively exhausted CD8
+ T cells (Saurw-
ein-Teissl et al., 2002; Effros et al., 2005). Furthermore, we
used bone-derived mesenchymal stem cells (Fehrer et al.,
2007; Laschober et al., 2009), foreskin (Oender et al., 2008),
as well as CD8
+ CD28
+ T cells from old versus young donors
(Lazuardi et al., 2009). Detailed characterization of these mod-
els as well as an overview over biological and technical repli-
cates and experimental design is presented in the supplements
(Figs S1 and S2a). Experiments were approved by the local eth-
ical committees, and written informed consent is available
from all donors.
Locked nucleic acid (LNA)-miRNA microarrays were spotted
(Castoldi et al., 2006) using Sanger miRBase v9.2 (Grifﬁths-
Jones et al., 2008) probe sets consisting of 559 human, 170
mouse, and 77 not yet annotated (miRPlus sequences; Exiqon
Inc., Vedbaek, Denmark) miRNA probes. Microarray design, a
comprehensive set of related protocols as well as raw and nor-
malized intensity data have been submitted to Array Express
Database compliant to Minimum Information About a Micro-
array Experiment standards (Brazma et al., 2001; Brazma,
2009). For Array Express accession numbers and detailed materi-
als and methods see Data S1 and Fig. S2a.
Depending on the experimental system, statistical analysis
identiﬁed 10–20% of the miRNAs as regulated, while the major-
ity remained unchanged during aging (Table S1). Applying
hierarchical clustering of all regulated miRNAs, members of the
(a)
(c)
(b)
Fig. 1 Microarray analysis of differential expression and enrichment of regulated miRNAs in replicative and organismal aging. (a) Size-adjusted Venn diagram
depicting the intersection of regulated miRNAs from replicative and organismal aging models: the upper, yellow circle represents ﬁve miRNAs that were found
signiﬁcantly regulated (false discovery rate-adjusted P-value < 0.05) in at least three of the four replicative models. Only miRNAs with uniform up- or down-
regulation in all models were considered. For organismal aging experiments, 34 miRNAs were signiﬁcantly regulated (FDR-adjusted P-value < 0.05) in at least two
of three models, indicated by the lower, purple circle. (b) The intersection contains three miRNAs of the miR-17-92 cluster, namely miR-17, miR-19b, and miR-20a,
as well as miR-106a of the paralogous miR-106a-363 cluster. The individual ‘old vs. young’ ratios for these miRNAs, calculated from microarray data, are depicted
in a barchart. (c) Fold changes in transcription of young vs. old based on microarrays are given for all members of the miR-17-92 cluster as well as selected miRNAs
from paralogous clusters together with 5¢ seed sequences. Adjusted P-values < 0.05 are marked in bold and underlined format, indicating statistically signiﬁcant
regulation.
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292miR-17-92 cluster and paralogous clusters stood out as being
commonly down-regulated (Fig. S3).
Using linear models and moderated T-statistics (Smyth, 2004)
in combination with false discovery rate (FDR) adjustment
according to Hochberg-Benjamini (1990), we calculated differ-
ential expression of miRNAs (FDR-adjusted P-value < 0.05) for
each of the seven model systems independently (available as
tab-delimited sheet in Table S2). Intersections of these lists of
regulated miRNAs were then analyzed for the replicative aging
models and the ex vivo models, which resulted in ﬁve miRNAs
with common expression changes in replicative aging, and 34
miRNAs that changed expression during organismal aging
(Fig. 1a). Interestingly, both replicative and organismal aging
share a common set of four miRNAs (‘public miRNAs’) that
belong to the miR-17-92 cluster or its paralogous cluster miR-
106a-363 and are down-regulated in both conditions (Fig. 1b).
Figure 1b shows that microarray analysis identiﬁed miR-17 as
signiﬁcantly down-regulated in all seven model systems, while
miR-19b and miR-20a are down-regulated in six and miR-106a
in ﬁve of the seven model systems. Interestingly, three of these
four miRNAs also share the same seed sequence (Fig. 1c) indi-
cating a cooperative relief of translational inhibition of a com-
mon and important set of target genes. Although low
transcription levels of mature miR-17 have been found in S
phase cells compared to G0⁄G1 and G2⁄M phase HeLa cells
(Cloonan et al., 2008), our result is not a mere growth arrest
phenomenon, as miR-17 and miR-19b are not regulated in
young replicating vs. quiescent endothelial cells (data not
shown).
Using quantitative polymerase chain reaction, we conﬁrmed
the down-regulation of miR-17, miR-19b, miR-20a, and miR-
106a (Fig. 2a) but observed a greater dynamic range in fold
changes ranging up to a 6-fold down-regulation, thus indicating
an even stronger decrease in the transcription of all four miRNAs
with age.
Down-regulation of members of the miR-17-92 cluster has
been reported recently in age-related conditions like in stress-
induced senescence (Li et al., 2009a), after p53 induction (Brosh
et al., 2008) as well as after low level irradiation (Maes et al.,
2008a,b) of human ﬁbroblasts.
However, other reports on differential expression of miRNAs
in replicative senescence of ﬁbroblasts (Brosh et al., 2008; Lal
et al., 2008; Bhaumik et al., 2009; Maes et al., 2009), in senes-
cence of mesenchymal stem cells (Wagner et al., 2008), of
human and mouse brain tissue (Lukiw, 2007; Li et al., 2009b) as
well as of murine liver (Maes et al., 2008a,b) and lung (Williams
et al., 2007; Izzotti et al., 2009) do not explicitly report regula-
tion of miR-17-92 miRNAs. This might either be because of the
fact that in some studies only up-regulated miRNAs have been
reported or to the strategy that only at least 2-fold changed
miRNAs were considered.
As the ability of array platforms to detect fold changes
down to 1.3-fold (Wurmbach et al., 2003) and because LNA-
based microarray methodology is considered to be one of
the most sensitive and reliable at the moment (Willenbrock
et al., 2009), we included miR-17-92 cluster members that
are signiﬁcantly regulated even at levels below 2-fold, even
more so, because array results also are reported to have the
tendency to underestimate the ratios (Wurmbach et al.,
2003).
Interestingly, among the published targets of the miR-17-92,
cluster is p21⁄CDKN1A mRNA (Ivanovska et al., 2008; Inomata
(a)
(b)
Fig. 2 Quantitative real-time polymerase chain reaction (PCR) of miRNAs
and the published target p21 ⁄ CDKN1A. (a) Down-regulation of miR-17, miR-
19b, miR-20a, and miR-106a in microarray experiments was validated by
quantitative PCR analysis. miRNA expression values were normalized to
GAPDH levels for each experiment (n =8 ;P < 0.05, one sample t-test with
l0 = 0) (b) Messenger RNA levels of p21 ⁄CDKN1A were analyzed by
quantitative polymerase chain reaction and normalized to GAPDH expression
levels (n =8 ;P < 0.05, one sample t-test with l0 = 0). Increased p21 levels
were observed in senescence and organismal aging indicating negative
correlation to transcription of members of the miR-17-92 cluster. HDF: human
diploid ﬁbroblasts, HUVEC: human umbilical vein endothelial cells, RPTEC:
renal proximal tubular epithelial cells, MSC: bone marrow derived
mesenchymal stem cells, FSK: human foreskin, GAPDH: Glycerinaldehyd-3-
phosphat-Dehydrogenase.
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correlated in all model systems (Fig. 2b), although the ratio in
old vs. young T cells does not reach signiﬁcance.
These data indicate that the miR-17-92 cluster, which is
known to contribute to transcriptional regulation in cell cycle
control and tumorigenesis (He et al., 2005), also contributes to
transcriptional regulation in senescence and aging, consistent
with the known interdependence between senescence and
tumorigenesis (Campisi, 2003; Rodier et al., 2007).
Among others, E2F transcriptionally activates (Woods et al.,
2007) and p53 represses the miR-17-92 cluster (Yan et al.,
2009). Thus, decreased miR-17-92 levels are consistent with the
notion that, E2F family members decrease (Dimri et al., 1994),
while p53 activity increases in senescence (Atadja et al., 1995;
Kulju & Lehman, 1995).
Downstream of miR-17-92 are 19 experimentally conﬁrmed
mRNA targets besides p21. Many of them are involved in
tumorigenesis and cell cycle control (Table S3). Indeed, miR-
17-92 suppression induces growth arrest in anaplastic thyroid
cancer cell models (Takakura et al., 2008). Furthermore, an
increase in the level of miR-17-92 is associated with a decrease
in ROS and DNA damage in RB mutated tumor cells (Ebi et al.,
2009). It will be exciting to test in an experimental system
whether a decrease in miR-17-92, as detected in our models
of aging, conversely results in more ROS and DNA damage,
both well accepted driving forces of age-related functional
decline.
In summary, our results implicate speciﬁc changes of miRNA
abundance and activity in a broad range of human aging models
and suggest the use of miR-17, miR-19b, miR-20a, and miR-106
as novel biomarkers of cellular aging.
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